Cargando…
Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma
High-dose-rate interstitial brachytherapy (HDR-ISBT) has recently come to be considered one of the most effective treatments for oral cancer. On the other hand, it is important to note that radiation therapy has some side effects. Especially, radiation-induced malignancy is probably the most serious...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528838/ https://www.ncbi.nlm.nih.gov/pubmed/36199998 http://dx.doi.org/10.5114/jcb.2022.116149 |
_version_ | 1784801374069850112 |
---|---|
author | Uchimoto, Yuka Shimamoto, Hiroaki Takeshita, Ami Oya, Kaori Kishino, Mitsunobu Fukuda, Yasuo Toyosawa, Satoru Oda, Michio Ogawa, Kazuhiko Kreiborg, Sven Mallya, Sanjay M. Murakami, Shumei |
author_facet | Uchimoto, Yuka Shimamoto, Hiroaki Takeshita, Ami Oya, Kaori Kishino, Mitsunobu Fukuda, Yasuo Toyosawa, Satoru Oda, Michio Ogawa, Kazuhiko Kreiborg, Sven Mallya, Sanjay M. Murakami, Shumei |
author_sort | Uchimoto, Yuka |
collection | PubMed |
description | High-dose-rate interstitial brachytherapy (HDR-ISBT) has recently come to be considered one of the most effective treatments for oral cancer. On the other hand, it is important to note that radiation therapy has some side effects. Especially, radiation-induced malignancy is probably the most serious complication affecting long-term survivors. We report a case of a radiation-induced undifferentiated spindle cell sarcoma that developed following HDR-ISBT for tongue squamous cell carcinoma (SCC). A 39-year-old woman with right tongue SCC underwent HDR-ISBT (60 Gy, 10 fractions, 8 days) treatment. Five years and one month later, a tumor had developed at the primary site. Surgery was performed for the tumor, which was histopathologically diagnosed as an undifferentiated spindle cell sarcoma. That was distinct from the squamous cell origin of the primary cancer. According to recently established criteria for radiation-induced malignancy, this case was classified as a radiation-induced sarcoma. A search of the literature revealed no previous report of radiation-induced malignancy following HDR-ISBT for tongue cancer. |
format | Online Article Text |
id | pubmed-9528838 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-95288382022-10-04 Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma Uchimoto, Yuka Shimamoto, Hiroaki Takeshita, Ami Oya, Kaori Kishino, Mitsunobu Fukuda, Yasuo Toyosawa, Satoru Oda, Michio Ogawa, Kazuhiko Kreiborg, Sven Mallya, Sanjay M. Murakami, Shumei J Contemp Brachytherapy Case Report High-dose-rate interstitial brachytherapy (HDR-ISBT) has recently come to be considered one of the most effective treatments for oral cancer. On the other hand, it is important to note that radiation therapy has some side effects. Especially, radiation-induced malignancy is probably the most serious complication affecting long-term survivors. We report a case of a radiation-induced undifferentiated spindle cell sarcoma that developed following HDR-ISBT for tongue squamous cell carcinoma (SCC). A 39-year-old woman with right tongue SCC underwent HDR-ISBT (60 Gy, 10 fractions, 8 days) treatment. Five years and one month later, a tumor had developed at the primary site. Surgery was performed for the tumor, which was histopathologically diagnosed as an undifferentiated spindle cell sarcoma. That was distinct from the squamous cell origin of the primary cancer. According to recently established criteria for radiation-induced malignancy, this case was classified as a radiation-induced sarcoma. A search of the literature revealed no previous report of radiation-induced malignancy following HDR-ISBT for tongue cancer. Termedia Publishing House 2022-05-11 2022-06 /pmc/articles/PMC9528838/ /pubmed/36199998 http://dx.doi.org/10.5114/jcb.2022.116149 Text en Copyright © 2022 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) ) |
spellingShingle | Case Report Uchimoto, Yuka Shimamoto, Hiroaki Takeshita, Ami Oya, Kaori Kishino, Mitsunobu Fukuda, Yasuo Toyosawa, Satoru Oda, Michio Ogawa, Kazuhiko Kreiborg, Sven Mallya, Sanjay M. Murakami, Shumei Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma |
title | Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma |
title_full | Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma |
title_fullStr | Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma |
title_full_unstemmed | Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma |
title_short | Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma |
title_sort | radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528838/ https://www.ncbi.nlm.nih.gov/pubmed/36199998 http://dx.doi.org/10.5114/jcb.2022.116149 |
work_keys_str_mv | AT uchimotoyuka radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma AT shimamotohiroaki radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma AT takeshitaami radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma AT oyakaori radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma AT kishinomitsunobu radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma AT fukudayasuo radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma AT toyosawasatoru radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma AT odamichio radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma AT ogawakazuhiko radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma AT kreiborgsven radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma AT mallyasanjaym radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma AT murakamishumei radiationinducedundifferentiatedspindlecellsarcomafollowinghighdoserateinterstitialbrachytherapyfortonguesquamouscellcarcinoma |